CoChat

Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections

Open access
Spacova, Irina, De Boeck, Ilke, Cauwenberghs, Eline, Delanghe, Lize, Bron, Peter A., Henkens, Tim, Simons, Alix, Gamgami, Imane, Persoons, Leentje, Claes, Ingmar, van den Broek, Marianne F. L., Schols, Dominique, Delputte, Peter, Coenen, Samuel, Verhoeven, Veronique, Lebeer, Sarah · 2023 · Microbial Biotechnology
Cited by 36

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Respiratory viruses such as influenza viruses, respiratory syncytial virus (RSV), and coronaviruses initiate infection at the mucosal surfaces of the upper respiratory tract (URT), where the resident respiratory microbiome has an important gatekeeper function. In contrast to gut‐targeting administration of beneficial bacteria against respiratory viral disease, topical URT administration of probiotics is currently underexplored, especially for the prevention and/or treatment of viral infections. Here, we report the formulation of a throat spray with live lactobacilli exhibiting several in vitro mechanisms of action against respiratory viral infections, including induction of interferon regulatory pathways and direct inhibition of respiratory viruses. Rational selection of Lactobacillaceae strains was based on previously documented beneficial properties, up‐scaling and industrial production characteristics, clinical safety parameters, and potential antiviral and immunostimulatory efficacy in the URT demonstrated in this study. Using a three‐step selection strategy, three strains were selected and further tested in vitro antiviral assays and in formulations: Lacticaseibacillus casei AMBR2 as a promising endogenous candidate URT probiotic with previously reported barrier‐enhancing and anti‐pathogenic properties and the two well‐studied model strains Lacticaseibacillus rhamnosus GG and Lactiplantibacillus plantarum WCFS1 that display immunomodulatory capacities. The three strains and their combination significantly reduced the cytopathogenic effects of RSV, influenza A/H1N1 and B viruses, and HCoV‐229E coronavirus in co‐culture models with bacteria, virus, and host cells. Subsequently, these strains were formulated in a throat spray and human monocytes were employed to confirm the formulation process did not reduce the interferon regulatory pathway‐inducing capacity. Administration of the throat spray in healthy volunteers revealed that the lactobacilli were capable of temporary colonization of the throat in a metabolically active form. Thus, the developed spray with live lactobacilli will be further explored in the clinic as a potential broad‐acting live biotherapeutic strategy against respiratory viral diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1751-7915.14189

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 36

Metadata

Authors
Spacova, I., De Boeck, I., Cauwenberghs, E., Delanghe, L., Bron, P. A., Henkens, T., Simons, A., Gamgami, I., Persoons, L., Claes, I., van den Broek, M. F. L., Schols, D., Delputte, P., Coenen, S., Verhoeven, V., & Lebeer, S.
Venue
Microbial Biotechnology
Publisher
Wiley
Published
2022-12-05
Volume
16
Issue
1
Pages
99-115
ISSN
1751-7915 (ISSN-L)
OpenAlex
W4310701645
Cited by
36
References
9
FWCI
3.58
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections. https://app.cochat.ai/papers/10.1111/1751-7915.14189
The paper
Spacova, I., De Boeck, I., Cauwenberghs, E., Delanghe, L., Bron, P. A., Henkens, T., Simons, A., Gamgami, I., Persoons, L., Claes, I., van den Broek, M. F. L., Schols, D., Delputte, P., Coenen, S., Verhoeven, V., & Lebeer, S. (2023). Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.14189

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.